The FDA on Thursday approved Allergan's antibiotic, Avycaz, to treat two forms of pneumonia, reports Reuters.
The agency first approved Avycaz in 2015 to treat adults with intra-abdominal infections in combination with metronidazole. In 2016, the FDA OK'd the antibiotic to treat complicated urinary tract infections and kidney infections.
Clinicians may now use Avycaz to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, both caused by drug-resistant bacteria.